EE
Easom Eric
董事长兼首席执行官
C-suiteM
内部人交易记录
首席执行官基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Explore the detailed record of transactions filed by Easom Eric, 董事长兼首席执行官. Officer active across 1 company, notably AN2 Therapeutics, Inc.. Cumulatively, 16 filings have been published. Breakdown: 3 buys · 8 sells. Total volume traded: €717k. Activity tracked since 20 October 2022. The latest transaction was disclosed on 20 February 2026 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Easom Eric
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报16 总计
112,250 股0Common StockSEC:0001193125-26-064151:0
10,000 股@ US$1.06651.3% 占其流量Common StockSEC:0000950170-25-081041:0
145,250 股0Common StockSEC:0000950170-25-030041:0
50,000 股@ US$0.99946.6% 占其流量Common StockSEC:0000950170-24-128202:0
99,000 股0Common StockSEC:0001610717-24-000191:0
99,000 股0Common StockSEC:0001610717-24-000164:0
2,777 股@ US$20.09457.1% 占其流量Common StockSEC:0001610717-24-000013:0
10,000 股@ US$5.3776.9% 占其流量Common StockSEC:0000899243-23-013012:0
4,413 股@ US$15.32489.4% 占其流量Common StockSEC:0000899243-22-035782:0
5,800 股@ US$15.411712.4% 占其流量Common StockSEC:0000899243-22-035472:0
11,082 股@ US$15.672524.7% 占其流量Common StockSEC:0000899243-22-035311:0
2,688 股@ US$15.38795.8% 占其流量Common StockSEC:0000899243-22-034840:0
924 股@ US$15.35712.0% 占其流量Common StockSEC:0000899243-22-034497:0
2,866 股@ US$16.17016.5% 占其流量Common StockSEC:0000899243-22-034294:0
7,262 股@ US$16.681417.3% 占其流量Common StockSEC:0000899243-22-034092:0
4,907 股Common StockSEC:0000899243-22-012989:0
About Easom Eric
Easom Eric is President-Directeur Général and Chief Executive Officer at AN2 Therapeutics, Inc. He has filed 16 forms in total, and in the 16 recent filings available, the transactions amount to 106199 EUR of buys and 610777 EUR of sales, between 2022-03-31 and 2026-02-23. The most frequent transaction nature is Sale.